BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10357088)

  • 1. The thrombophilic state in acute promyelocytic leukemia.
    Tallman MS
    Semin Thromb Hemost; 1999; 25(2):209-15. PubMed ID: 10357088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
    Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
    Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The double hazard of thrombophilia and bleeding in acute promyelocytic leukemia.
    Tallman MS; Abutalib SA; Altman JK
    Semin Thromb Hemost; 2007 Jun; 33(4):330-8. PubMed ID: 17525890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The unique hemostatic dysfunction in acute promyelocytic leukemia.
    Kwaan HC
    Semin Thromb Hemost; 2014 Apr; 40(3):332-6. PubMed ID: 24590422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
    Breccia M; Lo Coco F
    Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.
    De Stefano V; Teofili L; Sica S; Mastrangelo S; Di Mario A; Rutella S; Salutari P; Rumi C; d'Onofrio G; Leone G
    Blood; 1995 Nov; 86(9):3535-41. PubMed ID: 7579461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-trans-retinoic acid and arsenic trioxide as initial therapy for acute promyelocytic leukemia.
    Quezada G; Kopp L; Estey E; Wells RJ
    Pediatr Blood Cancer; 2008 Jul; 51(1):133-5. PubMed ID: 18293388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haemostatic problems in acute promyelocytic leukaemia.
    Arbuthnot C; Wilde JT
    Blood Rev; 2006 Nov; 20(6):289-97. PubMed ID: 16757074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute promyelocytic leukemia in pregnancy: all-trans retinoic acid as a newer therapeutic option.
    Celo JS; Kim HC; Houlihan C; Canavan BF; Manzullo GP; Saidi P
    Obstet Gynecol; 1994 May; 83(5 Pt 2):808-11. PubMed ID: 8159357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Leukemogenesis and therapy of acute promyelocytic leukemia: from the worse to the most favorable subtype of acute myeloid leukemia].
    KorĂ­stek Z; Mayer J
    Vnitr Lek; 2008; 54(7-8):701-27. PubMed ID: 18780571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promyelocytic extracellular chromatin exacerbates coagulation and fibrinolysis in acute promyelocytic leukemia.
    Cao M; Li T; He Z; Wang L; Yang X; Kou Y; Zou L; Dong X; Novakovic VA; Bi Y; Kou J; Yu B; Fang S; Wang J; Zhou J; Shi J
    Blood; 2017 Mar; 129(13):1855-1864. PubMed ID: 28053193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Zubizarreta PA; Rose AB; Felice MS; Alfaro E; Delfino S; Cygler AM; Sackmann-Muriel F
    Pediatr Hematol Oncol; 2000 Mar; 17(2):155-62. PubMed ID: 10734658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the pathogenesis of coagulation dysfunction in acute promyelocytic leukemia.
    Tallman MS; Hakimian D; Kwaan HC; Rickles FR
    Leuk Lymphoma; 1993 Sep; 11(1-2):27-36. PubMed ID: 8220153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. All trans retinoic acid.
    Advani SH
    J Assoc Physicians India; 1995; Suppl 3():65-6. PubMed ID: 8773125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of acute leukemia by differentiation: effects of all trans retinoic acid in acute promyelocytic leukemia].
    Degos L
    Nouv Rev Fr Hematol (1978); 1993 Jun; 35(3):193-5. PubMed ID: 8337123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N
    Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid improvement of coagulopathy by all-trans retinoic acid in acute promyelocytic leukemia.
    Kawai Y; Watanabe K; Kizaki M; Murata M; Kamata T; Uchida H; Moriki T; Yokoyama K; Tokuhira M; Nakajima H
    Am J Hematol; 1994 Jul; 46(3):184-8. PubMed ID: 8192147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Oudijk EJ; Nieuwenhuis HK; Bos R; Fijnheer R
    Thromb Haemost; 2000 Jun; 83(6):906-8. PubMed ID: 10896247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.